Your browser doesn't support javascript.
Palliative and Supportive Care Prescribing Considerations Around QT Prolongation Risk in the Context of COVID-19 (Coronavirus Disease 2019) Management.
J Pain Palliat Care Pharmacother ; 34(4): 237-239, 2020 Dec.
Article in English | MEDLINE | ID: covidwho-786937
ABSTRACT
COVID-19 brings with it unprecedented challenges in clinical management. An important component of care is the provision of safe and effective symptom control. Given the emerging literature reporting on the risk of QT prolongation and arrhythmias associated with COVID-19 disease and experimental therapies, we highlight some considerations for the prescribing of palliative care medications in this context. Based on the experience gained from palliative care referrals at our institution prior to and during the COVID-19 pandemic, and in collaboration with our clinical pharmacology colleagues, we outline some general prescribing principles which may assist with weighing the risks and benefits of prescribing symptomatic medications in and beyond the current pandemic.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Palliative Care / Arrhythmias, Cardiac / Long QT Syndrome / COVID-19 Drug Treatment Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Pain Palliat Care Pharmacother Journal subject: Neurology / Psychophysiology / Drug Therapy Year: 2020 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Palliative Care / Arrhythmias, Cardiac / Long QT Syndrome / COVID-19 Drug Treatment Type of study: Prognostic study Topics: Long Covid Limits: Humans Language: English Journal: J Pain Palliat Care Pharmacother Journal subject: Neurology / Psychophysiology / Drug Therapy Year: 2020 Document Type: Article